Website for the Talecris TALENTS Program visit the global Talecris website
Home The Program How to Apply Program Focus Previous Awardees Timelines

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, and hemostasis. Talecris is proudly building upon a 60-year legacy of innovation and a commitment to improving the lives of people who rely on its therapeutic products. With an emphasis on scientific inquiry and technological excellence, Talecris is expanding its current portfolio of products, programs, and services through its own world-class product development organization as well as through strategic initiatives that leverage its strengths with those of its partners.

Talecris, which earns revenues of over $1 billion per year, is headquartered in biotech hub Research Triangle Park, N.C., and employs more than 4,000 talented people worldwide.

To learn more about Talecris and how our employees are making a difference in the lives of patients and the healthcare community, visit www.talecris.com

 

Talecris links

The Talecris New Trials Support (Talents) Program is a novel initiative from Talecris Biotherapeutics that has been established to support investigator-initiated trials conceived by researchers and clinicians with an interest in using intravenous immunoglobulin (IGIV) in areas such as immunology, hematology, and neurology. Every year the Talents Program will provide $1 million to fund basic science and clinical research in these fields.

Talecris Biotherapeutics is currently reorganizing the Talents program in order to extend research support for investigators undertaking research in immunology, neurology, hematology, and pulmonary.  Please check back periodically at this website for additional information.

Talents Timelines: In 2010, letters of intent are due in by August 1st, 2010.  Disbursements of grants will begin in January 2011.

© 2010 Talecris Biotherapeutics

Contact us about out TALENTS program Sitemap for the TALENTS website Website for Talecris Biotherapeutics